AOXING PHARMACEUTICAL COMPANY, INC.: 10-Q/A filed 2012-10-01

Name: AOXING PHARMACEUTICAL COMPANY, INC.: 10-Q/A filed 2012-10-01
Creator: AOXING PHARMACEUTICAL COMPANY, INC.

What AOXING PHARMACEUTICAL COMPANY, INC. reported in its quarterly report amendment filed 2012-10-01 (fiscal Q3 2012): 36 published measures, 95 facts as tagged in accession 0001096906-12-002482.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2012-10-01
Fiscal period: fiscal Q3 2012
Accession: 0001096906-12-002482 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AOXING PHARMACEUTICAL COMPANY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-03-31	58,700,409	USD
At 2011-06-30	55,873,724	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-03-31	35,723,970	USD
At 2011-06-30	36,307,351	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-03-31	3,902,723	USD
At 2011-06-30	2,770,744	USD
At 2011-03-31	3,117,787	USD
At 2010-06-30	3,985,710	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-605,492	USD	91
2011-07-01 to 2012-03-31	-1,825,312	USD	275
2011-01-01 to 2011-03-31	-513,114	USD	90
2010-07-01 to 2011-03-31	-1,217,308	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-1,543,613	USD	275
2010-07-01 to 2011-03-31	-2,513,482	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	195,472	USD	275
2010-07-01 to 2011-03-31	1,136,634	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,807,284	USD	91
2011-07-01 to 2012-03-31	5,461,685	USD	275
2011-01-01 to 2011-03-31	1,628,627	USD	90
2010-07-01 to 2011-03-31	5,309,839	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	2,863,735	USD	275
2010-07-01 to 2011-03-31	2,305,463	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-195,472	USD	275
2010-07-01 to 2011-03-31	-843,738	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-03-31	-24,834,760	USD
At 2011-06-30	-23,009,448	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2011-01-01 to 2011-03-31	-280,004	USD	90
2010-07-01 to 2011-03-31	-672,214	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-03-31	26,758,871	USD
At 2011-06-30	26,669,156	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-436,952	USD	91
2011-07-01 to 2012-03-31	-1,083,770	USD	275
2011-01-01 to 2011-03-31	-1,123,904	USD	90
2010-07-01 to 2011-03-31	-2,921,179	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-03-31	9,894,223	USD
At 2011-06-30	7,378,195	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-03-31	18,394,858	USD
At 2011-06-30	14,635,762	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-03-31	2,592,242	USD
At 2011-06-30	2,659,727	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2012-03-31	20,293,321	USD
At 2011-06-30	19,916,128	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-03-31	2,681,589	USD
At 2011-06-30	2,008,024	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,447,555	USD	91
2011-07-01 to 2012-03-31	4,242,879	USD	275
2011-01-01 to 2011-03-31	1,945,039	USD	90
2010-07-01 to 2011-03-31	5,820,385	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-03-31	1,577,500	USD
At 2011-06-30	1,469,417	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,010,603	USD	91
2011-07-01 to 2012-03-31	3,159,109	USD	275
2011-01-01 to 2011-03-31	821,135	USD	90
2010-07-01 to 2011-03-31	2,899,206	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	103,237	USD	91
2011-07-01 to 2012-03-31	364,177	USD	275
2011-01-01 to 2011-03-31	70,362	USD	90
2010-07-01 to 2011-03-31	347,760	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-03-31	49,469,837	shares
At 2011-06-30	49,158,955	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-03-31	2,638,402	USD
At 2011-06-30	1,885,531	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2012-03-31	35,119,616	USD
At 2011-06-30	35,708,753	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-03-31	1,328,246	USD
At 2011-06-30	1,388,704	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-03-31	1,732,411	USD
At 2011-06-30	1,130,010	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-621,052	USD	91
2011-07-01 to 2012-03-31	-1,870,693	USD	275
2011-01-01 to 2011-03-31	-849,119	USD	90
2010-07-01 to 2011-03-31	-2,023,965	USD	274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-621,052	USD	91
2011-07-01 to 2012-03-31	-1,870,693	USD	275
2011-01-01 to 2011-03-31	-569,115	USD	90
2010-07-01 to 2011-03-31	-1,351,751	USD	274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-379,268	USD	91
2011-07-01 to 2012-03-31	-1,072,441	USD	275
2011-01-01 to 2011-03-31	-426,431	USD	90
2010-07-01 to 2011-03-31	-301,452	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	699,678	USD	91
2011-07-01 to 2012-03-31	2,210,489	USD	275
2011-01-01 to 2011-03-31	1,364,117	USD	90
2010-07-01 to 2011-03-31	3,785,867	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-184,100	USD	91
2011-07-01 to 2012-03-31	-786,923	USD	275
2011-01-01 to 2011-03-31	274,785	USD	90
2010-07-01 to 2011-03-31	897,214	USD	274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2010-07-01 to 2011-03-31	-672,214	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	643,460	USD	275
2010-07-01 to 2011-03-31	1,389,515	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	86,294	USD	275
2010-07-01 to 2011-03-31	350,696	USD	274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-179,633	USD	275
2010-07-01 to 2011-03-31	601,753	USD	274

Inspect the source

Entity: AOXING PHARMACEUTICAL COMPANY, INC. / CIK 0001060426
Captured: 2026-09-22 19:38 UTC
SEC response SHA-256: 7853980521379aa80eabc6640ead2d1c15a35f6d0a4bbda971e1bfc382d7827d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001060426.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))